FC25: Leveraging Gene Expression Profiling to Optimize Management and Empower Patients With Skin Cancers
Released on
October 23, 2025
FC25: Leveraging Gene Expression Profiling to Optimize Management and Empower Patients With Skin Cancers
This activity is supported by an educational grant from Castle Biosciences, Inc.